The anal fistula PLUG versus the mucosal flap advancement for the treatment of perianal fistulas

ISRCTN ISRCTN97376902
DOI https://doi.org/10.1186/ISRCTN97376902
Protocol serial number N/A
Sponsor Academic Medical Centre (AMC) (The Netherlands)
Funder Academic Medical Centre (AMC) (The Netherlands)
Submission date
16/07/2007
Registration date
16/07/2007
Last edited
31/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr J.F.M. Slors
Scientific

Academic Medical Centre
Afd. Chirurgie
Amsterdam
1105 AZ
Netherlands

Phone +31 (0)20 566 9111
Email j.f.slors@amc.uva.nl

Study information

Primary study designInterventional
Study designMulticentre, randomised, double blinded, active controlled, parallel group trial
Secondary study designRandomised controlled trial
Scientific titleThe anal fistula PLUG versus the mucosal flap advancement for the treatment of perianal fistulas
Study acronymPLUG
Study objectivesThe anal fistula plug is superior in the treatment of high transphincteric fistulas compared to the mucosal advancement flap.
Ethics approval(s)Approval received from the Medical Ethics Committee AMC, Amsterdam on the 23rd August 2006 (ref: MEC 06/204).
Health condition(s) or problem(s) studiedPerianal fistula
Interventioninstallation of the anal fistula plug versus mucosal flap.
Intervention typeOther
Primary outcome measure(s)

1. Anorectal fistula closure rate
2. Continence

Key secondary outcome measure(s)

1. Morbidity
2. Post-operative pain
3. Sick leave
4. Quality of life

Completion date01/10/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target sample size at registration60
Total final enrolment60
Key inclusion criteria1.High anorectal fistula of cryptoglandular origin (transphincteric, upper 2/3 of the sphincter complex which is confined by the puborectal sling and the end of the anal canal)
2. Informed consent
Key exclusion criteria1. Aged less than 18 years
2. Human Immunodeficiency Virus (HIV)-positive
3. Crohn's disease
4. Malignant cause
5. Tuberculosis
6. Hidradenitis suppurativa
7. Pilonidal sinus disease
8. No internal opening found during surgery
Date of first enrolment01/10/2006
Date of final enrolment01/10/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Academic Medical Centre
Amsterdam
1105 AZ
Netherlands

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2011 31/12/2020 Yes No
Protocol article protocol 23/06/2008 31/12/2020 Yes No

Editorial Notes

31/12/2020: The following changes have been made:
1. Publication references added.
2. The final enrolment number has been added from the reference.